)
)
)
Pharvaris
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to potentially address all types of bradykinin-mediated angioedema, including HAE.
Address
ZugSwitzerland
Switzerland
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)